Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras

Author:

Keskin Sarp K.1,Msaouel Pavlos2,Hess Kenneth R.3,Yu Kai-Jie14,Matin Surena F.1,Sircar Kanishka5,Tamboli Pheroze5,Jonasch Eric2,Wood Christopher G.1,Karam Jose A.1,Tannir Nizar M.2

Affiliation:

1. Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas

2. Department of Genitourinary Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas

3. Department of Biostatistics, University of Texas M. D. Anderson Cancer Center, Houston, Texas

4. Division of Urology, Department of Surgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan

5. Department of Pathology, University of Texas M. D. Anderson Cancer Center, Houston, Texas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference30 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Surveillance strategies for renal cell carcinoma patients following nephrectomy;Chin;Rev Urol,2006

3. Sarcomatoid renal cell carcinoma. A treatable entity;Sella;Cancer,1987

4. Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma;Mian;J Urol,2002

5. Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome;Cheville;Am J Surg Pathol,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3